Longitudinal MRI atrophy biomarkers: Relationship to conversion in the ADNI cohort

Shannon L. Risacher, Li Shen, John D. West, Sungeun Kim, Brenna C. McDonald, Laurel A. Beckett, Danielle J. Harvey, Clifford R Jr. Jack, Michael W. Weiner, Andrew J. Saykin

Research output: Contribution to journalArticle

156 Citations (Scopus)

Abstract

Atrophic changes in early Alzheimer's disease (AD) and amnestic mild cognitive impairment (MCI) have been proposed as biomarkers for detection and monitoring. We analyzed magnetic resonance imaging (MRI) atrophy rate from baseline to 1 year in 4 groups of participants from the Alzheimer's Disease Neuroimaging Initiative (ADNI): AD (n = 152), converters from MCI to probable AD (MCI-C, n = 60), stable MCI (MCI-S, n = 261), and healthy controls (HC, n = 200). Scans were analyzed using multiple methods, including voxel-based morphometry (VBM), regions of interest (ROIs), and automated parcellation, permitting comparison of annual percent change (APC) in neurodegeneration markers. Effect sizes and the sample required to detect 25% reduction in atrophy rates were calculated. The influence of APOE genotype on APC was also evaluated. AD patients and converters from MCI to probable AD demonstrated high atrophy APCs across regions compared with minimal change in healthy controls. Stable MCI subjects showed intermediate atrophy rates. APOE genotype was associated with APC in key regions. In sum, APC rates are influenced by APOE genotype, imminent MCI to AD conversion, and AD-related neurodegeneration.

Original languageEnglish (US)
Pages (from-to)1401-1418
Number of pages18
JournalNeurobiology of Aging
Volume31
Issue number8
DOIs
StatePublished - Aug 2010

Fingerprint

Neuroimaging
Atrophy
Alzheimer Disease
Biomarkers
Magnetic Resonance Imaging
Genotype
Cognitive Dysfunction
Sample Size

Keywords

  • Alzheimer's Disease Neuroimaging Initiative (ADNI)
  • Apolipoprotein E (APOE) epsilon 4 allele
  • Genetic factors
  • Hippocampus
  • Longitudinal change
  • Magnetic resonance imaging (MRI)
  • Mild cognitive impairment (MCI)
  • Voxel-based morphometry (VBM)

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)
  • Aging
  • Developmental Biology
  • Geriatrics and Gerontology

Cite this

Risacher, S. L., Shen, L., West, J. D., Kim, S., McDonald, B. C., Beckett, L. A., ... Saykin, A. J. (2010). Longitudinal MRI atrophy biomarkers: Relationship to conversion in the ADNI cohort. Neurobiology of Aging, 31(8), 1401-1418. https://doi.org/10.1016/j.neurobiolaging.2010.04.029

Longitudinal MRI atrophy biomarkers : Relationship to conversion in the ADNI cohort. / Risacher, Shannon L.; Shen, Li; West, John D.; Kim, Sungeun; McDonald, Brenna C.; Beckett, Laurel A.; Harvey, Danielle J.; Jack, Clifford R Jr.; Weiner, Michael W.; Saykin, Andrew J.

In: Neurobiology of Aging, Vol. 31, No. 8, 08.2010, p. 1401-1418.

Research output: Contribution to journalArticle

Risacher, SL, Shen, L, West, JD, Kim, S, McDonald, BC, Beckett, LA, Harvey, DJ, Jack, CRJ, Weiner, MW & Saykin, AJ 2010, 'Longitudinal MRI atrophy biomarkers: Relationship to conversion in the ADNI cohort', Neurobiology of Aging, vol. 31, no. 8, pp. 1401-1418. https://doi.org/10.1016/j.neurobiolaging.2010.04.029
Risacher, Shannon L. ; Shen, Li ; West, John D. ; Kim, Sungeun ; McDonald, Brenna C. ; Beckett, Laurel A. ; Harvey, Danielle J. ; Jack, Clifford R Jr. ; Weiner, Michael W. ; Saykin, Andrew J. / Longitudinal MRI atrophy biomarkers : Relationship to conversion in the ADNI cohort. In: Neurobiology of Aging. 2010 ; Vol. 31, No. 8. pp. 1401-1418.
@article{eda4d96fba034e6b92ec5db62ecf18fe,
title = "Longitudinal MRI atrophy biomarkers: Relationship to conversion in the ADNI cohort",
abstract = "Atrophic changes in early Alzheimer's disease (AD) and amnestic mild cognitive impairment (MCI) have been proposed as biomarkers for detection and monitoring. We analyzed magnetic resonance imaging (MRI) atrophy rate from baseline to 1 year in 4 groups of participants from the Alzheimer's Disease Neuroimaging Initiative (ADNI): AD (n = 152), converters from MCI to probable AD (MCI-C, n = 60), stable MCI (MCI-S, n = 261), and healthy controls (HC, n = 200). Scans were analyzed using multiple methods, including voxel-based morphometry (VBM), regions of interest (ROIs), and automated parcellation, permitting comparison of annual percent change (APC) in neurodegeneration markers. Effect sizes and the sample required to detect 25{\%} reduction in atrophy rates were calculated. The influence of APOE genotype on APC was also evaluated. AD patients and converters from MCI to probable AD demonstrated high atrophy APCs across regions compared with minimal change in healthy controls. Stable MCI subjects showed intermediate atrophy rates. APOE genotype was associated with APC in key regions. In sum, APC rates are influenced by APOE genotype, imminent MCI to AD conversion, and AD-related neurodegeneration.",
keywords = "Alzheimer's Disease Neuroimaging Initiative (ADNI), Apolipoprotein E (APOE) epsilon 4 allele, Genetic factors, Hippocampus, Longitudinal change, Magnetic resonance imaging (MRI), Mild cognitive impairment (MCI), Voxel-based morphometry (VBM)",
author = "Risacher, {Shannon L.} and Li Shen and West, {John D.} and Sungeun Kim and McDonald, {Brenna C.} and Beckett, {Laurel A.} and Harvey, {Danielle J.} and Jack, {Clifford R Jr.} and Weiner, {Michael W.} and Saykin, {Andrew J.}",
year = "2010",
month = "8",
doi = "10.1016/j.neurobiolaging.2010.04.029",
language = "English (US)",
volume = "31",
pages = "1401--1418",
journal = "Neurobiology of Aging",
issn = "0197-4580",
publisher = "Elsevier Inc.",
number = "8",

}

TY - JOUR

T1 - Longitudinal MRI atrophy biomarkers

T2 - Relationship to conversion in the ADNI cohort

AU - Risacher, Shannon L.

AU - Shen, Li

AU - West, John D.

AU - Kim, Sungeun

AU - McDonald, Brenna C.

AU - Beckett, Laurel A.

AU - Harvey, Danielle J.

AU - Jack, Clifford R Jr.

AU - Weiner, Michael W.

AU - Saykin, Andrew J.

PY - 2010/8

Y1 - 2010/8

N2 - Atrophic changes in early Alzheimer's disease (AD) and amnestic mild cognitive impairment (MCI) have been proposed as biomarkers for detection and monitoring. We analyzed magnetic resonance imaging (MRI) atrophy rate from baseline to 1 year in 4 groups of participants from the Alzheimer's Disease Neuroimaging Initiative (ADNI): AD (n = 152), converters from MCI to probable AD (MCI-C, n = 60), stable MCI (MCI-S, n = 261), and healthy controls (HC, n = 200). Scans were analyzed using multiple methods, including voxel-based morphometry (VBM), regions of interest (ROIs), and automated parcellation, permitting comparison of annual percent change (APC) in neurodegeneration markers. Effect sizes and the sample required to detect 25% reduction in atrophy rates were calculated. The influence of APOE genotype on APC was also evaluated. AD patients and converters from MCI to probable AD demonstrated high atrophy APCs across regions compared with minimal change in healthy controls. Stable MCI subjects showed intermediate atrophy rates. APOE genotype was associated with APC in key regions. In sum, APC rates are influenced by APOE genotype, imminent MCI to AD conversion, and AD-related neurodegeneration.

AB - Atrophic changes in early Alzheimer's disease (AD) and amnestic mild cognitive impairment (MCI) have been proposed as biomarkers for detection and monitoring. We analyzed magnetic resonance imaging (MRI) atrophy rate from baseline to 1 year in 4 groups of participants from the Alzheimer's Disease Neuroimaging Initiative (ADNI): AD (n = 152), converters from MCI to probable AD (MCI-C, n = 60), stable MCI (MCI-S, n = 261), and healthy controls (HC, n = 200). Scans were analyzed using multiple methods, including voxel-based morphometry (VBM), regions of interest (ROIs), and automated parcellation, permitting comparison of annual percent change (APC) in neurodegeneration markers. Effect sizes and the sample required to detect 25% reduction in atrophy rates were calculated. The influence of APOE genotype on APC was also evaluated. AD patients and converters from MCI to probable AD demonstrated high atrophy APCs across regions compared with minimal change in healthy controls. Stable MCI subjects showed intermediate atrophy rates. APOE genotype was associated with APC in key regions. In sum, APC rates are influenced by APOE genotype, imminent MCI to AD conversion, and AD-related neurodegeneration.

KW - Alzheimer's Disease Neuroimaging Initiative (ADNI)

KW - Apolipoprotein E (APOE) epsilon 4 allele

KW - Genetic factors

KW - Hippocampus

KW - Longitudinal change

KW - Magnetic resonance imaging (MRI)

KW - Mild cognitive impairment (MCI)

KW - Voxel-based morphometry (VBM)

UR - http://www.scopus.com/inward/record.url?scp=77953998854&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953998854&partnerID=8YFLogxK

U2 - 10.1016/j.neurobiolaging.2010.04.029

DO - 10.1016/j.neurobiolaging.2010.04.029

M3 - Article

C2 - 20620664

AN - SCOPUS:77953998854

VL - 31

SP - 1401

EP - 1418

JO - Neurobiology of Aging

JF - Neurobiology of Aging

SN - 0197-4580

IS - 8

ER -